Telemedicine Technologies
develops e-Health solutions
to reinvent the organisation of healthcare in 5 key domains
Clinical Research
A flexible and modular offer that fully meets your needs…
Managed Access Programmes
Ethical and compliant mechanism for access to drugs…
Real-World Evidence & Registries
Support for healthcare professionals in the technical implementation of registry databases and set-up of monitoring indicators …
Patient Pathway
Plan, rationalise and standardise the care of your patients through medical protocols…
Investigator site Management
For an efficient Site Management in Clinical Research...
DISCOVER
eCRF • ePRO/eCOA • eConsent • IWRS • IMP Management Vigilance •
Imaging • eTMF • CTMS • rSDV • MAP
Do you want to learn more about our e-health solution? Just fill in the form and we will get back to you shortly
OUR SERVICES
Data Services
WE CARE FOR YOU DATA
Quality of Data through comprehensive clinical Data Management...
AI & Data Visualisation
ARTIFICIAL INTELLIGENCE EMPOWERING OUR SOLUTIONS AND DATA SERVICES
Advanced data processing based on machine learning and advanced statistics
Training
SKILLS TRANSFER & END-USER AUTONOMY
Our training courses have been awarded the national Qualiopi certification…
User Support
AVAILABLE IN FRENCH AND ENGLISH
User support is available in both French and English...
Hosting
SECURE OR HEALTH DATA HOSTING SERVICES
Secure hosting or Health Data Hosting services, at your convenience...
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
MEMBER OF
SUPPORTED BY
LATEST NEWSOUR NEWS >
April 29, 2025
May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]
April 29, 2025
Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]
April 29, 2025
Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]